Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID-19 in multiple sclerosis patients and risk factors for severe infection.

Journal of the neurological sciences - 15 Nov 2020

Chaudhry Farhan, Bulka Helena, Rathnam Anirudha S, Said Omar M, Lin Jia, Lorigan Holly, Bernitsas Eva, Rube Jacob, Korzeniewski Steven J, Memon Anza B, Levy Phillip D, Schultz Lonni, Javed Adil, Lisak Robert, Cerghet Mirela

Abstract excerpt

Multiple sclerosis (MS) patients have been considered a higher-risk population for COVID-19 due to the high prevalence of disability and disease-modifying therapy use; however, there is little data identifying clinical characteristics of MS associated with worse COVID-19 outcomes. Therefore, we conducted a multicenter prospective cohort study looking at the outcomes of 40 MS patients with confirmed COVID-19....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Comorbidity
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disability Evaluation

Share to Hospitalization

Share to Intensive Care Units

Share to Multiple Sclerosis

Share to Pandemics

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 32980780
DOI: 10.1016/j.jns.2020.117147
PMCID: PMC7834402

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID-19 in multiple sclerosis patients and risk factors for severe infection.PMID 32980780Read ↗

COVID-19 in Multiple Sclerosis Patients and Risk Factors for Severe InfectionSemantic proximity Read ↗

COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextSemantic proximity Read ↗

Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort StudySemantic proximity Read ↗

Disease Modifying Therapies and COVID-19 Severity in Multiple SclerosisSemantic proximity Read ↗

Associations of DMT therapies with COVID-19 severity in multiple sclerosisSemantic proximity Read ↗

COVID-19 OUTCOMES IN MS: EARLY EXPERIENCE FROM NYU MULTIPLE SCLEROSIS COMPREHENSIVE CARE CENTERSemantic proximity Read ↗

SARS-CoV-2 infection among patients with multiple sclerosis; A cross-sectional studySemantic proximity Read ↗

Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.Semantic proximity Read ↗

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.Semantic proximity Read ↗

Increased Rate of Hospitalisation for COVID-19 Amongst Rituximab Treated Multiple Sclerosis Patients: A Study of the Swedish MS RegistrySemantic proximity Read ↗

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).Semantic proximity Read ↗

New multiple sclerosis phenotypic classification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.